Type 2 Diabetes Research Study

Type 2 diabetes is a progressive condition that is currently affecting about 30 million Americans. In most cases, type 2 diabetes leads to, or is accompanied by, high cholesterol and heart diseases. Despite available treatments, there is a significant need for options that achieve acceptable blood sugar control and lowers cholesterol levels.

Accellacare is enrolling participants across multiple diabetes research studies. Submit your interest form to discover which study may be best for you!

Eligible volunteers will receive study-related care and study medication at no cost. Financial compensation will also be provided for time and travel expenses.

Submit to learn more:

Have you been diagnosed with Type 2 Diabetes? *

Yes

Prefer not to say

Do you currently take a stable dose of metformin for your diabetes? *

Yes

Prefer not to say

Do you currently take a stable dose of an oral SGLT2 medication alone, or in combination with metformin (ie: Invokana, Farxiga, Jardiance, etc)? *

Yes

Prefer not to say

Do you currently take a GLP-1 medication? (Ozempic, Victoza, Saxenda, Trulicity, etc) *

Yes

Prefer not to say

Have you had a recent A1c Blood Test in the range of 7% - 10.5%? *

Yes - in the last 3 months

Yes - in the last 6 months

Yes - in the last 12 months

No - my last A1c was out of range

Unsure of last test

Do you have any history of cardiovascular conditions or chronic kidney disease (that doesn’t require dialysis)? *

Yes

Prefer not to say

What is your height? (ex: 5'8")

What is your weight? (We use this to calculate BMI)

First Name *

Last Name *

Email Address *

Zip Code *

Phone Number (inc. area code)* *

**By registering and providing your telephone number, you agree to receive text messages from Accellacare for the purposes above at the number you provide. Message and data rates may apply. Message frequency will vary. No mobile information will be shared with third parties/affiliates for marketing/promotional purposes. For help, reply HELP to any message. To opt-out, reply STOP to any message.

Select your nearest clinic *

When you register your interest with Accellacare (which is part of ICON plc), our team will add your information to our database, review your information and connect you with studies that you may be eligible for. When we find a match, Accellacare clinical research specialists will contact you directly for further pre-screening by phone and may refer you on to Accellacare sites or collaborating third-party sites for further on-site pre-screening. We may also contact you in the future by phone call, text message, or email regarding future trials you may be interested in based on the information you provide to us. The clinic you choose in the registration form below may be a third-party study site (which will be clearly indicated) that collaborates with Accellacare on clinical trials. If you select a third-party site, you agree that we may share your personal data with that clinic for further pre-screening. That clinic will be independently responsible for processing your personal data in accordance with all applicable data protection laws.

Data Protection

ICON plc is responsible for the personal data, including data related to your health, race, and ethnicity you choose to provide. We rely on your consent to add your information to our database, use this information to identify potentially appropriate clinical studies for you and contact you about them. When we call you for further pre-screening, note that these calls will be recorded. If you have selected a third-party site, we will share your information with this site so they can contact you for further pre-screening.

You can withdraw your consent at any time, for example by following instructions to do so in emails or text messages you receive from us, or by telling our patient recruitment team when speaking with them. This does not affect the lawfulness of the processing prior to your withdrawal. Additional information on how your data will be processed and how you can exercise your rights, can be found in our Privacy Policy. Please confirm if you consent to ICON plc collecting, using and sharing your personal data for the above purposes. *

I Agree

Please enter the security code: